PDCD1 and melanoma: Harel et al. (24) employed LC–tandem mass spectrometry (MS/MS) to analyze protein extracts from tissue biopsies of patients with melanoma treated with immunotherapies including PD-1 blockade, discovering that treatment response was associated with enriched mitochondrial lipid metabolism.